Cardiac Output Monitoring to Predict Pre-Eclampsia and Restricted Growth (COMPaRE)
Launched by SANDWELL & WEST BIRMINGHAM HOSPITALS NHS TRUST · Nov 16, 2021
Trial Information
Current as of May 14, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Pregnant women aged ≥18 at time of conception
- • Case subjects are at high risk of PET by NICE guidelines ( ≥1 high risk factor or \>1 moderate risk factor) or high risk of SGA by RCOG Guidelines (≥1 major risk factor or ≥3 minor risk factors). Control subjects do not meet this criteria
- Exclusion Criteria:
- • Maternal age \<18 years of age at time of booking
- • Fetal structural or genetic abnormality
- • Multiple pregnancy
- • Known underlying maternal cardiac condition
About Sandwell & West Birmingham Hospitals Nhs Trust
Sandwell and West Birmingham Hospitals NHS Trust is a dedicated healthcare organization committed to delivering high-quality patient care and advancing medical research through innovative clinical trials. With a focus on improving health outcomes, the Trust collaborates with various stakeholders to facilitate research initiatives that encompass a wide range of medical disciplines. Their comprehensive approach integrates clinical expertise, patient involvement, and cutting-edge technology, positioning them as a leader in the NHS in promoting evidence-based medicine and enhancing treatment options for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials